Business Wire

Eigenmann & Veronelli inaugurates its new Group application laboratory for the Beauty & Personal Care, and Paint & Coatings markets


Eigenmann & Veronelli, a leading player in the sales, marketing and distribution of specialty chemicals and food ingredients, today announced the opening of the new Beauty & Personal Care, and Paint & Coatings laboratory to serve its customers and best-in-class suppliers throughout the EMEA region.

This press release features multimedia. View the full release here:

To view this piece of content from, please give your consent at the top of this page.

Photographed (Left to Right): Ludovico Balbo di Vinadio, Shareholder and Board Member, Eigenmann & Veronelli; Elena Zambon, President, Zambon S.p.A; Corrado Bestetti, Shareholder and Board Member, Eigenmann & Veronelli; Nathalie Veronelli, Shareholder and Board Member, Eigenmann & Veronelli; Gabriele Bonomi, Group Chief Executive Officer, Eigenmann & Veronelli; Christian Veronelli, Shareholder and President, Eigenmann & Veronelli (Photo: Business Wire)

Located in Bresso, on the doorstep of Milan, Italy, the new 230 square metre laboratory – part of the OpenZone scientific campus, a place that embodies the exchange of knowledge between research and business – expands the EV ’s technical capabilities to now include Paint & Coatings, and Beauty & Personal Care, in addition to its existing technical capabilities in the food sector.

“The opening of the EV Group Academy Center on the doorstep of Milan reinforces our commitment to serve our supplier partners and customers not only as a distributor, but also as a formulator and solutions provider, driving innovation in the business,” said Gabriele Bonomi, EV Group CEO. “This is just the beginning of further investments to strengthen our services and technical capabilities in the EMEA region, fostering our commitment to creating value for partners.”

“We are really glad to welcome Eigenmann & Veronelli at OpenZone and happy to see how our campus is confirming itself as the ideal place to do research, innovation and foster successful entrepreneurial projects,” commented Alessio Pinciroli, General Manager at OpenZone. “We believe in the power of open innovation and collaboration, and we are confident that Eigenmann & Veronelli will be able to bring their vast experience and know-how to the benefit of our community and the industry”.

The new laboratory is designed to support customers and suppliers by providing formulation, training, plus customer seminars and academies, support, and guidance alongside innovative materials and concepts. The laboratory is fully equipped for developing formulations, solving technical problems, and providing technical assistance.

Part of a network of 4 laboratories with market-focused experts who exchange knowledge and formulation expertise, the new facility was designed to hold future investments in expanding EV’s technical support into make-up, skin care, hair care, and construction, decorative paints, industrial coatings, wood coatings, inks & pigments, and adhesives markets.

About Eigenmann & Veronelli S.p.A.

Eigenmann & Veronelli is an international solutions provider of specialty chemicals and food ingredients. Headquartered in Rho (MI), Italy, EV has a direct presence in Italy, Iberia, Turkey and U.A.E. and a commercial reach in more than 40 countries. In 2022, EV generated a consolidated turnover of 417 million EUR with more than 350 employees. The Company is synonymous with effectiveness and efficiency, that combining local market knowledge with international chemical innovations, to offering a high-quality and diversified portfolio of specialty chemicals and ingredients as well as tailor-made application, marketing and supply chain solutions, technical and formulation support, comprehensive regulatory know-how for a wide range of industries.

For more information, visit:

Follow us on LinkedIn.

About OpenZone

OpenZone is the campus, on the doorstep of Milan, dedicated to Health and founded on an approach geared towards open innovation. Conceived to build bridges between different languages and worlds, OpenZone mission is to “uniquely create value in Healthcare, by fostering community, competencies and capital”. Today the campus is home to 34 enterprises, including some of the foremost biotechnology, pharmaceutical and advanced gene therapy companies, all with a strong penchant for innovation. OpenZone covers a surface area of 37,000 square metres, with the capacity to host up to 1,200 people. OpenZone works closely with all stakeholders in the Health sector, to ensure that Milan and Lombardy are increasingly recognized internationally as a territory of excellence for life sciences.

Learn more on:

To view this piece of content from, please give your consent at the top of this page.

Contact information

For further enquiries, please contact:
Federica Urso - Group Corporate Communication Manager, EV S.p.A
Mob. +39 338.7295116 @:

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

VIOOH Shares Industry-first Carbon Emissions Measurement Hitting 18% Below Benchmark11.12.2023 09:00:00 CET | Press release

Today, VIOOH, the leading premium global digital out of (DOOH) home supply-side platform, announced a partnership with the Carbon Intelligence Platform, Cedara, a supporter of Ad Net Zero. In an industry first for a programmatic DOOH (prDOOH) player, VIOOH has shared publicly its impression intensity carbon emissions (grams CO2e) per ad impression for 2022, which is 18% below the programmatic open web benchmark. Based on Cedara’s measurement, VIOOH generated 0.28 grams CO2e per ad impression in 2022, well below the Cedara ad platform benchmark of 0.34, which is based on programmatic open web vendor data. VIOOH worked closely with Cedara on a comprehensive greenhouse gas (GHG) inventory assessment across its operations, including programmatic media activity, which contributes the majority of Scope 3 emissions. As part of its measurement process, Cedara not only analysed data sets from business operations, but also activity data from media delivery, data centres, and media owners, amongs

Hexadrone Starts C5 and C6 Drone Type Examination After Successful GAP Analysis of The TUNDRA 2’ Specification by Notified Body11.12.2023 08:30:00 CET | Press release

Hexadrone SAS, A French Modular UAV’s Manufacturer Created in 2014 has successfully completed GAP Analysis for The Tundra 2 in its Urban and Endurance versions versus DR EU 2019/945 with intension for Class Identification Label C5 and C6. With the achievement of this milestone, the certification process for both Urban and Endurance Version have been now formally triggered by Hexadrone to be performed by the notified body NavCert GmbH. The Tundra 2 is bringing on the market a key differentiator by providing extreme modularity on UAVs, integrating unlimited type of payloads used in various sectors like, Surveillance, Geospatial, Agriculture, Oil and gas, Military, Homeland security, Rescue and much more. “Through an in-depth analysis based on European Union (EU) Regulation 2019/945, we have ensured that the specifications of the Tundra 2 as well as our user manuals fully meet the current requirements. This compliance will ensure that the TUNDRA 2 users will be able to fly in European air

VINSSEN Co., Ltd. Successfully Supplies Hydrogen Fuel Cell for Industry Project in Singapore11.12.2023 08:00:00 CET | Press release

VINSSEN Co., Ltd. (CEO Chil-Han Lee), a company specializing in the production of electric and hydrogen hybrid propulsion systems, has successfully tested and delivered a hydrogen fuel cell system for a trial project involving several key industry partners. This press release features multimedia. View the full release here: Hydrogen fuel cell power generation equipment is undergoing inspection before delivery (Photo: VINSSEN Co., Ltd.) VINSSEN is collaborating with Shell Singapore Pte. Ltd. (Shell) as the project sponsor, Seatrium Limited as the project developer, Penguin International Limited as the owner and operator of the vessel, and Air Liquide Singapore Private Limited as the hydrogen supplier. This project is a pilot to test the use of hydrogen fuel cells in maritime applications, marking the first step in confirming feasibility of hydrogen as a marine fuel. The hydrogen fuel cell system has been delivered from Korea and

New Study Finds Significant Correlation Between Masimo ORi™ and Arterial Partial Pressure of Oxygen During One-Lung Ventilation11.12.2023 08:00:00 CET | Press release

Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the Journal of Anesthesia in which Dr. Yu Jeong Bang and colleagues at the Samsung Medical Center, Sungkyunkwan University School of Medicine, in Seoul, South Korea, investigated the association of Masimo ORi™ and the arterial partial pressure of oxygen (PaO2) in 554 patients who underwent non-cardiac thoracic surgery during one-lung ventilation (OLV), making this study the largest to date on ORi. The researchers found that ORi values “were significantly correlated with PaO2 measured simultaneously” and that ORi “could provide useful information on arterial oxygenation even during one-lung ventilation.”1 This press release features multimedia. View the full release here: Masimo Root® with ORi™ (Photo: Business Wire) Noninvasive, continuous Masimo ORi provides continuous, real-time insight into the oxygenation of hemoglobin in the moderate hy

Ferring and PharmaBiome Enter Into a New Microbiome R&D Collaboration and Exclusive Licensing Agreement11.12.2023 07:00:00 CET | Press release

Ferring Pharmaceuticals and Zürich-based microbiome translation company PharmaBiome are today announcing a research and development collaboration to drive forward new microbiome-based biotherapeutics in the field of gastroenterology. This press release features multimedia. View the full release here: The deal provides Ferring with exclusive rights to develop, manufacture and commercialise next generation microbiome-based therapeutics within the field of gastroenterology arising out of the collaboration. The financial details of this deal are undisclosed. “This agreement is the latest in Ferring’s long term mission to maximise the therapeutic potential of the gut microbiome for the benefit of patients. PharmaBiome’s unique technology enables identification and manufacturing of defined consortium live microbiome biotherapeutics that could reverse microbiome dysbiosis linked to disease,” said Carl Bilbo, Senior Vice President, Micr